P11.17 Splicing dysregulation drives glioblastoma malignancy: SRSF3 as a potential therapeutic target to impair glioblastoma progression

Por Fuentes-Fayos, A C, Vázquez-Borrego, M C, Jiménez-Vacas, J M, Bejarano, L, Blanco-Acevedo, C, Sánchez-Sánchez, R, Solivera, J, Blasco, M A, Castaño, J P, Luque, R M
Publicado no Neuro Oncol (2019)